Literature DB >> 19946783

Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.

Michael J Goldacre1, Marie Duncan, Myfanwy Griffith, Martin R Turner.   

Abstract

The objective of this study is to report trends in mortality, as certified on death certificates, from multiple sclerosis (MS), motor neuron disease (MND), primary Parkinson's disease (PD), and epilepsy, analysing not only the underlying cause of death but also all certified causes for each disease. Death records in the Oxford region, 1979-2006, and England, 1996-2006, were analysed for ascertaining the trends in mortality. The percentage of deaths coded as the underlying cause changed over time, coinciding with changes to the rules for selecting the underlying cause of death. Changes over time to coding rules had a large impact on apparent trends in death rates for PD when studied by underlying cause alone. They also had significant, though smaller, effects on trends in death rates for MS, MND and epilepsy. Nationally, in the last period of the study, underlying cause mortality identified 64% of deaths with a mention of MS, 88% of MND, 56% of PD, and 48% of epilepsy. In the longstanding Oxford data from 1979 to 2006, death rates based on all certified causes of death showed no significant change for MS; an upward trend for MND (notably in women over 75), though only in the last few years of the study; a significant but small decline for PD; and no significant change for epilepsy. When mortality statistics are analysed by underlying cause only, their value is reduced. A substantial percentage of neurological deaths are missed. Time trends may be misleading. All certified causes for each disease, as well as the underlying cause, should be analysed.

Entities:  

Mesh:

Year:  2009        PMID: 19946783     DOI: 10.1007/s00415-009-5392-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

1.  Validity of mortality data for Parkinson's disease.

Authors:  N J Phillips; J Reay; C N Martyn
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

2.  Geographic and temporal distribution of mortality rates for multiple sclerosis in Canada, 1965-1994.

Authors:  Sharon Warren; K G Warren; Lawrence W Svenson; Donald P Schopflocher; Allyson Jones
Journal:  Neuroepidemiology       Date:  2003 Jan-Feb       Impact factor: 3.282

3.  Mortality rates from multiple sclerosis: geographical and temporal variations revisited.

Authors:  E S Williams; D R Jones; R O McKeran
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

4.  Clinical features and associations of 560 cases of motor neuron disease.

Authors:  T M Li; E Alberman; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

5.  Trends in epilepsy mortality in England and Wales and the United States, 1950-1994.

Authors:  F J O'Callaghan; C Osmond; C N Martyn
Journal:  Am J Epidemiol       Date:  2000-01-15       Impact factor: 4.897

6.  Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998.

Authors:  Curtis W Noonan; Mary C White; David Thurman; Lee-Yang Wong
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

7.  Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.

Authors:  A M Chancellor; R J Swingler; H Fraser; J A Clarke; C P Warlow
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

8.  Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975 - 2004.

Authors:  Thomas G Day; Martin Scott; Roslyn Perring; Pat Doyle
Journal:  Amyotroph Lateral Scler       Date:  2007-12

9.  Cause-specific mortality: understanding uncertain tips of the disease iceberg.

Authors:  M J Goldacre
Journal:  J Epidemiol Community Health       Date:  1993-12       Impact factor: 3.710

10.  Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.

Authors:  M R Turner; M Bakker; P Sham; C E Shaw; P N Leigh; A Al-Chalabi
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2002-03
View more
  15 in total

1.  Neuroepidemiology: The increasing burden of mortality from neurological diseases.

Authors:  Julia Pakpoor; Michael Goldacre
Journal:  Nat Rev Neurol       Date:  2017-08-11       Impact factor: 42.937

2.  Time Trends in the Incidence of Parkinson Disease.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

3.  Multiple cause of death analysis in multiple sclerosis: A population-based study.

Authors:  Katharine Harding; Feng Zhu; Mohammed Alotaibi; Thomas Duggan; Helen Tremlett; Elaine Kingwell
Journal:  Neurology       Date:  2020-01-13       Impact factor: 9.910

4.  Mortality of Parkinson's disease in Italy from 1980 to 2015.

Authors:  Monica Ulivelli; Daiana Bezzini; Lucia Kundisova; Ilaria Grazi; Mario Alberto Battaglia; Nicola Nante; Simone Rossi
Journal:  Neurol Sci       Date:  2022-01-30       Impact factor: 3.307

5.  Predictors of Mortality in Veterans with Multiple Sclerosis in an Outpatient Clinic Setting.

Authors:  Meheroz H Rabadi; Christopher E Aston
Journal:  Int J MS Care       Date:  2017 Sep-Oct

Review 6.  Seizure-related injuries, drowning and vehicular crashes -- a critical review of the literature.

Authors:  Michael Tan; Wendyl D'Souza
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

7.  Mortality from Parkinson's disease and other causes among a workforce manufacturing paraquat: a retrospective cohort study.

Authors:  John Andrew Tomenson; Clive Campbell
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

8.  Neurological deaths of American adults (55-74) and the over 75's by sex compared with 20 Western countries 1989-2010: Cause for concern.

Authors:  Colin Pritchard; Emily Rosenorn-Lanng
Journal:  Surg Neurol Int       Date:  2015-07-23

9.  Mortality from Parkinson's disease and other causes among a workforce manufacturing paraquat: an updated retrospective cohort study.

Authors:  John Andrew Tomenson; Clive Campbell
Journal:  J Occup Med Toxicol       Date:  2021-05-27       Impact factor: 2.646

10.  Co-morbidities of persons dying of Parkinson's disease.

Authors:  Lynn Lethbridge; Grace M Johnston; George Turnbull
Journal:  Prog Palliat Care       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.